In this article we discuss the Billionaire Paul Tudor Jones’ Top 5 Stock Picks. If you want to read our detailed analysis of Paul Tudor Jones’ hedge fund performance and returns, go directly to Billionaire Paul Tudor Jones’ Top 10 Stock Picks.
At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. Keeping this in mind let’s take a look at billionaire PTJ’s top 5 stock picks:
5. Aimmune Therapeutics, Inc. (NASDAQ: AIMT)
Aimmune Therapeutics, Inc. (NASDAQ: AIMT) was the fifth largest holding of Paul Tudor Jones. The fund manager initiated a position during the third quarter and became the top hedge fund investor in the company. His position was valued at $34.088 million and represented 1.5% of his overall fund holdings.
On August 31, 2020, Aimmune Therapeutics, Inc. entered into a definitive agreement pursuant to which Nestlé Health Science (NHSc) would acquire Aimmune for $2 billion.
The acquiring price was $34.50 per share. Shares were trading near $12.60 on August 28, 2020 before soaring to $34.17 following the announcement.